Clinical Trial Update: Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung [Phase 2]

View source ↗

Summary

Phase 2 trial assessing adjuvant pemetrexed plus cisplatin for lung adenocarcinoma reports efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Adenocarcinoma, Lung Neoplasm | Phase 2 | Status: COMPLETED